Artenimol

双氢青蒿素

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameArtenimol
Drug Alias NameDihydroqinghaosuDihydroartemisininCotecxin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 inhibitors
TargetsCytochrome P450
Therapy Area/IndicationsParturitionLupus Erythematosus, SystemicLupus Erythematosus, Discoid +[6] 
Global Approved IndicationsMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1992/01/01
Country/TerritorySwazilandUgandaMozambique +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Traditional Chinese Medicine Chinese Academy Of Traditional Chinese MedicineBarcelona Institute For Global HealthKpc Pharmaceuticals Inc
Inactive CompaniesUniversity Of California San FranciscoUniversity Of OxfordMakerere University
Active IndicationsParturitionLupus Erythematosus, SystemicLupus Erythematosus, Discoid +[5] 
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeP01BE05
Related LinksWikipediaDrugBankKEGG